Class information for:
Level 1: CANAVAN DISEASE//PROSTATE SPECIFIC MEMBRANE ANTIGEN//PSMA

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
8432 1184 38.7 80%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
3119 1786 CANAVAN DISEASE//PROSTATE SPECIFIC MEMBRANE ANTIGEN//PSMA

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CANAVAN DISEASE Author keyword 159 83% 8% 89
2 PROSTATE SPECIFIC MEMBRANE ANTIGEN Author keyword 110 61% 10% 116
3 PSMA Author keyword 100 59% 9% 111
4 N ACETYLASPARTYLGLUTAMATE Author keyword 91 78% 5% 60
5 ASPARTOACYLASE Author keyword 87 83% 4% 49
6 GLUTAMATE CARBOXYPEPTIDASE II Author keyword 68 80% 4% 43
7 NAALADASE Author keyword 64 86% 3% 32
8 NAAG Author keyword 50 71% 3% 40
9 N ACETYLASPARTIC ACID Author keyword 31 82% 2% 18
10 N ACETYLASPARTYLGLUTAMATE NAAG Author keyword 21 85% 1% 11

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 CANAVAN DISEASE 159 83% 8% 89 Search CANAVAN+DISEASE Search CANAVAN+DISEASE
2 PROSTATE SPECIFIC MEMBRANE ANTIGEN 110 61% 10% 116 Search PROSTATE+SPECIFIC+MEMBRANE+ANTIGEN Search PROSTATE+SPECIFIC+MEMBRANE+ANTIGEN
3 PSMA 100 59% 9% 111 Search PSMA Search PSMA
4 N ACETYLASPARTYLGLUTAMATE 91 78% 5% 60 Search N+ACETYLASPARTYLGLUTAMATE Search N+ACETYLASPARTYLGLUTAMATE
5 ASPARTOACYLASE 87 83% 4% 49 Search ASPARTOACYLASE Search ASPARTOACYLASE
6 GLUTAMATE CARBOXYPEPTIDASE II 68 80% 4% 43 Search GLUTAMATE+CARBOXYPEPTIDASE+II Search GLUTAMATE+CARBOXYPEPTIDASE+II
7 NAALADASE 64 86% 3% 32 Search NAALADASE Search NAALADASE
8 NAAG 50 71% 3% 40 Search NAAG Search NAAG
9 N ACETYLASPARTIC ACID 31 82% 2% 18 Search N+ACETYLASPARTIC+ACID Search N+ACETYLASPARTIC+ACID
10 N ACETYLASPARTYLGLUTAMATE NAAG 21 85% 1% 11 Search N+ACETYLASPARTYLGLUTAMATE+NAAG Search N+ACETYLASPARTYLGLUTAMATE+NAAG

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 LINKED ACIDIC DIPEPTIDASE 230 88% 9% 109
2 FOLATE HYDROLASE 144 91% 5% 60
3 NAALADASE 130 91% 4% 53
4 ACIDIC DIPEPTIDASE ACTIVITY 116 97% 3% 33
5 ASPARTOACYLASE DEFICIENCY 114 86% 5% 59
6 NAAG 90 88% 4% 43
7 N ACETYLASPARTIC ACIDURIA 74 84% 3% 41
8 GLUTAMATE CARBOXYPEPTIDASE II 69 52% 8% 95
9 ACETYL ASPARTYL GLUTAMATE 66 79% 4% 42
10 ASPARTYL L GLUTAMATE 65 90% 2% 28

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Prostate-specific membrane antigen-based imaging 2013 27 51 76%
N-acetylaspartate in the CNS: From neurodiagnostics to neurobiology 2007 385 328 32%
Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer 2012 23 197 79%
N-acetylaspartylglutamate: The most abundant peptide neurotransmitter in the mammalian central nervous system 2000 177 96 80%
PET Imaging in Prostate Cancer: Focus on Prostate-Specific Membrane Antigen 2013 25 122 52%
Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family 2011 22 90 86%
The prostate-specific membrane antigen: Lessons and current clinical implications from 20 years of research 2014 5 50 68%
Targeted Therapies for Prostate Cancer Against the Prostate Specific Membrane Antigen 2009 45 85 74%
Targeted systemic therapy of prostate cancer with a monoclonal antibody to prostate-specific membrane antigen 2003 77 20 90%
Technology Insight: monoclonal antibody imaging of prostate cancer 2006 52 41 71%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 NEUROTRANSLAT DRUG DISCOVERY PROGRAM 6 58% 0.6% 7
2 PHARMACEUT THER Y NEUROPHARMACOL 2 29% 0.6% 7
3 GEORGE M OBRIEN UROL 2 44% 0.3% 4
4 UNIT IMMUNOL MICROBIOL ENVIRONM CARCINOGENESI 2 44% 0.3% 4
5 PEDIAT HUMAN BIOL CHEM GENET 2 67% 0.2% 2
6 HUMAN DEV CONSUMER SCI 2 43% 0.3% 3
7 NSF BIOPHON SCI TECHNOL 1 100% 0.2% 2
8 CLIN STAND 1 20% 0.3% 4
9 IOCB 1 14% 0.5% 6
10 VERMONT GENET NETWORK 1 25% 0.3% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000112067 C 11 CHOLINE PET CT//C 11 CHOLINE//CHOLINE PET
2 0.0000104551 ZITTER RAT//ATTRACTIN//SPONTANEOUSLY EPILEPTIC RAT SER
3 0.0000069400 MULTIMERIC LIGANDS//NDP ALPHA MSH//DISSOCIATION ENHANCED LANTHANIDE FLUOROIMMUNOASSAY
4 0.0000060350 N ACETYL ASPARTATE//N ACETYLASPARTATE//MOL DYNAM MENTAL DISORDERS
5 0.0000059011 MAGNETIC RESONANCE SPECTROSCOPY//SPECTROSCOPIC IMAGING//LCMODEL
6 0.0000056679 PROSTATE STEM CELL ANTIGEN//PROSTATE STEM CELL ANTIGEN PSCA//PSCA
7 0.0000050926 ALEXANDER DISEASE//LEUKODYSTROPHY//VANISHING WHITE MATTER DISEASE
8 0.0000045943 AMINOACYLASE//D AMINOACYLASE//L AMINOACYLASE
9 0.0000042931 AXON MYELIN TRANSFER//MYELIN PHOSPHOINOSITIDES//SIGNAL TRANSDUCTION IN MYELIN
10 0.0000041555 HOMOCYSTEATE//QUISQUALATE//2 AMINO 4 PHOSPHONOBUTANOIC ACID